Susanne Prothon

Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects

Robert S. Palmer, Jukka Mäenpää, Alexandra Jauhiainen et al. · Clinical Pharmacology & Therapeutics · 2018 · 90 citations · Full text

Inflammation, Asthma, Anti-inflammatory +15

Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials

Tove Hegelund Myrbäck, Susanne Prothon, K. A. P. Edman et al. · The Lancet Rheumatology · 2019 · 24 citations

Versus Prednisolone, Medicine, Healthy Volunteers +6

Efficacy and Tolerability of an Inhaled Selective Glucocorticoid Receptor Modulator – AZD5423 – in Chronic Obstructive Pulmonary Disease Patients: Phase II Study Results

Piotr Kuna, Magnus Aurivillius, Carin Jorup et al. · Basic & Clinical Pharmacology & Toxicology · 2017 · 19 citations · Full text

Asthma, Gr Modulators, Allergy +9

Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different Devices

Johanna Melin, Susanne Prothon, Charlotte Kloft et al. · The AAPS Journal · 2017 · 15 citations

Asthma, Allergy, Respiratory Toxicology +5

Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator AZD5423 after Inhalation in Healthy Volunteers

Viktoría Werkström, Susanne Prothon, Ella Ekholm et al. · Basic & Clinical Pharmacology & Toxicology · 2016 · 13 citations

Asthma, Nebulized Azd5423, Plasma Exposure +11